Anti-Inflammatory Effects of Pioglitazone and/or Simvastatin in High Cardiovascular Risk Patients With Elevated High Sensitivity C-Reactive Protein-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anti-Inflammatory Effects of Pioglitazone and/or Simvastatin in High Cardiovascular Risk Patients With Elevated High Sensitivity C-Reactive Protein

Published:2007-01 Issue:3 Volume:49 Page:290-297
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Hanefeld Markolf,Marx Nikolaus,Pfützner Andreas,Baurecht Werner,Lübben Georg,Karagiannis Efstrathios,Stier Ulf,Forst Thomas

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference47 articles.

1. Inflammatory markers in coronary artery disease: let prevention douse the flames;Vorchheimer;JAMA,2001

2. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men;Ridker;N Engl J Med,1997

3. C-reactive protein and coronary heart disease;Ridker;N Engl J Med,2004

4. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women;Ridker;N Engl J Med,2000

5. C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany;Koenig;Circulation,2004

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adiponectin and Adiponectin Receptors in Atherosclerosis;Endocrine Reviews;2024-08-06

2. HOMA-IR as a Predictor of PAI-1 Levels in Women with Severe Obesity;Biomedicines;2024-05-31

3. PPARs in atherosclerosis: The spatial and temporal features from mechanism to druggable targets;Journal of Advanced Research;2024-03

4. Effects of pioglitazone and linagliptin on glycemic control, lipid profile and hs-CRP in metformin-treated patients with type 2 diabetes: a comparative study;Hormone Molecular Biology and Clinical Investigation;2023-12-01

5. Thiazolidinediones lower the risk of pneumonia in patients with type 2 diabetes;Frontiers in Microbiology;2023-02-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3